NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
27.00
1.34 (5.22%)
At close: Sep 05, 2025, 3:59 PM
27.00
0.00%
After-hours: Sep 05, 2025, 05:39 PM EDT
NewAmsterdam Pharma Revenue
NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a 257% growth. For the quarter ending June 30, 2025, NewAmsterdam Pharma generated $19.14M in revenue.
Revenue (ttm)
45.56M
Revenue Growth
257%
Price / Sales Ratio
53.22
Revenue / Employee
670.04K
Employees
68
Market Cap
3.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 45.56M | +257.00% |
| Dec 31, 2023 | 12.76M | -86.69% |
| Dec 31, 2022 | 95.91M | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |